Cytokine Gene Polymorphisms Are Associated with Disease Response to Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia

被引：0
|
作者：
Jeyakumar, Nikeshan [1 ]
Aldoss, Ibrahim [2 ]
Yang, Dongyun [3 ]
Mokhtari, Sally [4 ]
Gendzekhadze, Ketevan [5 ]
O'Donnell, Margaret [2 ]
Palmer, Joycelynne [6 ]
Song, Joo Y. [2 ]
Marcucci, Guido [2 ]
Stein, Anthony S. [2 ]
Forman, Stephen J. [7 ]
Pullarkat, Vinod A. [2 ]
Wu, Xiwei [2 ]
Nakamura, Ryotaro [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Internal Med, Houston, TX 77030 USA
[2] City Hope Natl Med Ctr, Dept Hematol HCT, 1500 E Duarte Rd, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Dept Informat Sci BRI, Duarte, CA 91010 USA
[4] City Hope Natl Med Ctr, Dept Clin Translat Program Dev, Duarte, CA 91010 USA
[5] City Hope Natl Med Ctr, Histocompatibil Lab, Duarte, CA 91010 USA
[6] City Hope Natl Med Ctr, Dept Informat Sci BRI, Duarte, CA USA
[7] City Hope Natl Med Ctr, Dept Hematol Hematopoiet Cell Transplantat, Duarte, CA USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116859
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1549
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Cytokine gene polymorphisms are associated with response to blinatumomab in B-cell acute lymphoblastic leukemia
    Jeyakumar, Nikeshan
    Aldoss, Ibrahim
    Yang, Dongyun
    Mokhtari, Sally
    Gendzekhadze, Ketevan
    Khaled, Samer
    O'Donnell, Margaret
    Palmer, Joycelynne
    Song, Joo Y.
    Marcucci, Guido
    Stein, Anthony S.
    Forman, Stephen J.
    Pullarkat, Vinod A.
    Chen, Wei
    Wu, Xiwei
    Nakamura, Ryotaro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (06) : 851 - 858
  • [2] Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Kantarjian, Hagop M.
    Brueggemann, Monika
    Stein, Anthony S.
    Bargou, Ralf C.
    Dombret, Herve
    Fielding, Adele K.
    Heffner, Leonard
    Rigal-Huguet, Francoise
    Litzow, Mark
    O'Brien, Susan
    Zugmaier, Gerhard
    Gao, Shan
    Nagorsen, Dirk
    Forman, Stephen J.
    Topp, Max S.
    BLOOD ADVANCES, 2019, 3 (20) : 3033 - 3037
  • [3] Immunological Response of Children With Relapse of B-Cell Precursor Acute Lymphoblastic Leukemia to Blinatumomab
    Pawinska-Wasikowska, K.
    Bukowska-Strakova, K.
    Surman, M.
    Siedlar, M.
    Balwierz, W.
    Skoczen, S.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S480 - S481
  • [4] COMPLETE RESPONSE TO BLINATUMOMAB IN AN UNUSUAL EXTRAMEDULLARY RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Cardinali, V.
    Laurenti, M. E.
    Marra, A.
    Martino, G.
    Brogna, M.
    Sciabolacci, S.
    Falini, B.
    Martelli, M. P.
    HAEMATOLOGICA, 2017, 102 : 75 - 75
  • [5] Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Dombret, Herve
    Bonifacio, Massimiliano
    Reichle, Albrecht
    Graux, Carlos
    Faul, Christoph
    Diedrich, Helmut
    Topp, Max S.
    Brueggemann, Monika
    Horst, Heinz-August
    Havelange, Violaine
    Stieglmaier, Julia
    Wessels, Hendrik
    Haddad, Vincent
    Benjamin, Jonathan E.
    Zugmaier, Gerhard
    Nagorsen, Dirk
    Bargou, Ralf C.
    BLOOD, 2018, 131 (14) : 1522 - 1531
  • [6] Blinatumomab in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Queudeville, Manon
    Schlegel, Patrick
    Heinz, Amadeus T.
    Lenz, Teresa
    Doering, Michaela
    Holzer, Ursula
    Hartmann, Ulrike
    Kreyenberg, Hermann
    von Stackelberg, Arend
    Schrappe, Martin
    Zugmaier, Gerhard
    Feuchtinger, Tobias
    Lang, Peter
    Handgretinger, Rupert
    Ebinger, Martin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 473 - 483
  • [7] Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults
    Lee, Kum Ja
    Chow, Vivian
    Weissman, Ashley
    Tulpule, Sunil
    Aldoss, Ibrahim
    Akhtari, Mojtaba
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1301 - 1310
  • [8] Blinatumomab to improve the outcome of children with relapsed B-cell acute lymphoblastic leukemia
    J. L. Fuster
    F. Bautista
    B. González
    J. M. Fernández
    S. Rives
    J. L. Dapena
    Clinical and Translational Oncology, 2021, 23 : 1963 - 1966
  • [9] Use of Blinatumomab for Relapse Therapy of B-Cell Precursor Acute Lymphoblastic Leukemia
    Pawinska-Wasikowska, K.
    Wyrobek, E.
    Klekawka, T.
    Luszawska-Kutrzeba, T.
    Garus, K.
    Pietrys, D.
    Zaniewska-Tekieli, A.
    Wieczorek, A.
    Balwierz, W.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S251 - S251
  • [10] The Usefulness of Blinatumomab for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Review
    Watakabe, Mai
    Arakawa, Yuki
    Irikura, Tomoya
    Honda, Mamoru
    Mitani, Yuichi
    Oshima, Koichi
    Watanabe, Atsuko
    Mori, Makiko
    Fukuoka, Kohei
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2021, 68
12345